PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

WuXi Biologics inks lease agreement for 3rd U.S. facility in global expansion push

WuXi Biologics is in the midst of gung-ho global expansion effort to spread the CDMO's roots outside of its Chinese home base. Only a month after announcing its firs...
Continue Reading →
News

Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs

Biopharma M&A has seen a sharp decline so far this year, both in terms of monetary value and total transaction count, amid a COVID-19 business slowdown. But is t...
Continue Reading →
News

Fujifilm plots $928M infusion at Danish biologics plant to double production capacity

Fujifilm made a massive investment in a former Biogen biologics facility in Denmark last year to help realize its global CDMO expansion plans. With that nearly $1 bi...
Continue Reading →
News

Sanofi’s Sarclisa rejected by NICE over uncertainties on total benefit, cost-effectiveness

Sanofi is making a push back into oncology led by multiple myeloma drug Sarclisa, its first wholly-owned cancer medicine in a decade. But now the company’s...
Continue Reading →
News

Italy’s Flamma quadruples R&D space to support API production in U.S.

Italian contract development and manufacturing organization Flamma SpA has spent the past three years boosting its pharmaceutical ingredient business&...
Continue Reading →
News

ECOLAB COMPLETE THEIR LOW RESIDUE LINE UP

Ecolab’s popular Klercide Low Residue Quat (KLRQ) range, a quaternary ammonium?based daily disinfectant  for cleanrooms is now complemented with the addition of K...
Continue Reading →
News

New US approval for AZ’ Brilinta

AstraZeneca’s Brilinta (ticagrelor) has been cleared by US regulators to cut the risk of a first heart attack or stroke in high-risk patients with coronary artery di...
Continue Reading →
News

Roche’s Tecentriq/Avastin combo wins US approval

Tecentriq in combination with Avastin is the first and only cancer immunotherapy regimen cleared to treat unresectable or metastatic liver cancer US regulators hav...
Continue Reading →
News

Sanofi’s Sarclisa cleared in Europe for multiple myeloma

European regulators have issued a green light for use of Sanofi's Sarclisa (isatuximab) to treat adults with relapsed and refractory multiple myeloma. The decision...
Continue Reading →
News

AbbVie files Rinvoq for psoriatic arthritis

AbbVie is seeking to expand the scope of Rinvoq (upadacitinib) in the US and Europe to include the treatment of adults with active psoriatic arthritis. The drugmak...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026